Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells.
about
Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant TumoursT-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motifp56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulationCTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cellsB7x: a widely expressed B7 family member that inhibits T cell activationUse and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectorsImmune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatmentUnderstanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpointsTwo distinct intracytoplasmic regions of the T-cell adhesion molecule CD28 participate in phosphatidylinositol 3-kinase associationThe current status of therapeutic HPV vaccineEvidence implicating the Ras pathway in multiple CD28 costimulatory functions in CD4+ T cellsMelanoma Peptide Vaccines.Tumor antigens and tumor vaccines: peptides as immunogens.Molecular genetic aspects of human cancers: the 1993 Frank Rose Lecture.Temporal transcriptome changes induced by MDV in Marek's disease-resistant and -susceptible inbred chickens.Immunity to breast cancer in mice immunized with fibroblasts transfected with a cDNA expression library derived from small numbers of breast cancer cells.Effect of B7.1 costimulation on T-cell based immunity against TAP-negative cancer can be facilitated by TAP1 expressionAdvances in cancer vaccine development.Genes that induce immunity--DNA vaccines.Association between the Cytotoxic T-lymphocyte antigen 4 +49G > A polymorphism and cancer risk: a meta-analysis.A Combination of Systemic and Intracranial Anti-CD25 Immunotherapy Elicits a Long-Time Survival in Murine Model of GliomaProgress in cancer gene therapy.Cross-presentation of tumour antigens: evaluation of threshold, duration, distribution and regulation.The B7/CD28/CTLA4 T-cell activation pathway. Implications for inflammatory lung disease.Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivoFollicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity.Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer modelCD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity.Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80).Human tumor-derived genomic DNA transduced into a recipient cell induces tumor-specific immune responses ex vivo.ProtEx technology for the generation of novel therapeutic cancer vaccinesTGF-beta-based immunotherapy for cancer: breaching the tumor firewall.Tumor cells engineered to codisplay on their surface 4-1BBL and LIGHT costimulatory proteins as a novel vaccine approach for cancer immunotherapyGene therapy: development of immunostimulatory treatments for cancer.Genome-wide analysis of molecular changes in IL-12-induced control of mammary carcinoma via IFN-gamma-independent mechanismsGene expression analysis in Interleukin-12-induced suppression of mouse mammary carcinomaInfluenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.Global gene expression profiling in interleukin-12-induced activation of CD8(+) cytotoxic T lymphocytes against mouse mammary CarcinomaRNA as a tumor vaccine: a review of the literature.Gene therapy in pancreatic cancer.
P2860
Q21284986-45108DB7-59B7-4D95-B1B8-80FC1384ACA8Q24310233-B0D7E664-621B-450B-9360-5681A0740F0EQ24311999-6C2EC6A2-44A1-4F78-9728-0D523C89136EQ24336526-99DF5E32-ED89-46CA-8A15-0E9804E114A3Q24683252-8EB04919-C04F-4A48-A15A-C68FD07550B9Q24803438-811F17F4-C2A0-465A-8205-301815B30832Q26738359-80382043-4CA3-493B-AB71-35A03E055180Q26801551-6B2BEB8D-B500-4F6D-BDFE-FFE3146FD232Q28277768-0770B7DA-6598-4A6B-93A1-AB4E25F1560FQ28302676-91F09A22-A2D9-4BA7-B142-1ECF63FAE69BQ28477140-78BAB0A5-1A83-485B-9E04-A0C47CC6A61CQ30305778-1635EC39-77AE-483D-A76E-CFF38BCD7323Q30469630-201F07CB-AC63-4BF1-9F77-7D2D375CC854Q30486859-1C5BADA0-43E6-4B6B-8C1A-DEB88380478FQ31033273-90F55B71-3488-4BE7-BD72-2B83A5C7E8AEQ33215427-20B79AE7-1DFA-442B-9A61-FFBBC4072AF6Q33486534-14083603-EF73-4D24-A82E-7A29B5271D57Q33603404-C22EFDF7-7BF7-44AB-B54B-A60B827B4A72Q33641393-1E3113D2-E85F-4130-87F6-DA7F969E399DQ33710123-D176A55B-6027-48D5-BFD8-05077C833CDEQ33743905-A3881192-856C-4500-BF32-79CB9F32E4F0Q33752288-7AF048EE-8641-444F-8F16-38DDCC8EF06FQ33778847-242845BC-5E8A-41BE-8179-DE1F82FA5490Q33850990-CBA9CA33-5D55-444F-A890-B267AE4C875DQ33870240-30F51E62-4920-415D-A341-9D199F523153Q33956237-A1C6C335-1F72-4A15-B683-A3FD0051B097Q33989165-D753FD5C-3860-4E4C-9062-A7EE021341A9Q34025520-11BD86A6-453E-45C0-884C-AE47D9E729CAQ34027192-34CCD284-A548-429E-98BD-EE98C2B37053Q34035529-2BA21FFF-13B0-44C5-96AE-FFC84F308A52Q34048819-D2467EED-74AD-4E23-9173-F28372766E6FQ34057799-94DDE0A6-B8E6-4458-BF47-8C2EB1B3E429Q34137777-F12A546C-87F1-4E69-8883-4F166369959BQ34187915-11AAB512-CE20-46E5-B7E6-82652E689AD0Q34209993-F710D2E7-1D54-4518-B266-4745372A5FD7Q34215458-C4B160E5-6CEC-413B-9D85-78CAC2601515Q34229490-257811D7-1E2F-47CD-B5F3-3F63AEB7092AQ34245822-3CDE6F3C-A8D5-469C-97F6-DEB923F34B4CQ34266409-47266C0C-4253-49AB-83F5-F16D44CC8E9BQ34302954-25C67B69-0816-436E-976A-6970F20F0BE2
P2860
Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Tumor rejection after direct c ...... B7-transfected melanoma cells.
@en
Tumor rejection after direct c ...... B7-transfected melanoma cells.
@nl
type
label
Tumor rejection after direct c ...... B7-transfected melanoma cells.
@en
Tumor rejection after direct c ...... B7-transfected melanoma cells.
@nl
prefLabel
Tumor rejection after direct c ...... B7-transfected melanoma cells.
@en
Tumor rejection after direct c ...... B7-transfected melanoma cells.
@nl
P356
P1433
P1476
Tumor rejection after direct c ...... B7-transfected melanoma cells.
@en
P2093
Allison JP
Townsend SE
P304
P356
10.1126/SCIENCE.7678351
P407
P577
1993-01-01T00:00:00Z